Shoreline Biosciences, Inc., a biopharmaceutical company developing next-generation cellular immunotherapies, announced the appointment of Mauro Avanzi, chief medical officer. Avanzi is an experienced physician-scientist and hematologist/oncologist with more than fifteen years of clinical experience, including over ten years of experience advancing cellular therapies through early and late-stage of development. In his new role, Dr. Avanzi will be responsible for leading and expanding ...